Ferox Therapeutics   Report issue

For profit Phase 1
Founded: Montclair NJ United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04026750
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ferox Therapeutics

Active Ingredients

Drugs in Phase 1 Trials (1)

pitolisant (Wakix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Hypoglycemia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1